Rodionova S S
Ter Arkh. 1995;67(10):43-5.
A 1-year administration of osteoquine (7-isopropoxyisoflavon) to 20 patients with postmenopausal and senile systemic osteoporosis has shown a pronounced analgetic effect of this drug, its ability to stop the loss of and in some instances to increase bone mass, to stimulate osteogenesis.
对20名绝经后和老年性全身性骨质疏松症患者进行为期1年的骨喹（7-异丙氧基异黄酮）给药，结果显示该药物具有显著的镇痛作用，能够阻止骨质流失，在某些情况下还能增加骨量，并刺激骨生成。
